Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 3
1991 2
1992 3
1993 3
1994 4
1995 2
1996 4
1997 3
1998 1
1999 2
2000 9
2001 2
2002 5
2003 4
2004 7
2005 6
2006 1
2007 3
2008 4
2009 7
2010 3
2011 4
2012 5
2013 7
2014 7
2015 5
2017 3
2018 2
2019 5
2020 3
2021 5
2022 5
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Betibeglogene Autotemcel Gene Therapy for Non-β00 Genotype β-Thalassemia.
Locatelli F, Thompson AA, Kwiatkowski JL, Porter JB, Thrasher AJ, Hongeng S, Sauer MG, Thuret I, Lal A, Algeri M, Schneiderman J, Olson TS, Carpenter B, Amrolia PJ, Anurathapan U, Schambach A, Chabannon C, Schmidt M, Labik I, Elliot H, Guo R, Asmal M, Colvin RA, Walters MC. Locatelli F, et al. Among authors: thuret i. N Engl J Med. 2022 Feb 3;386(5):415-427. doi: 10.1056/NEJMoa2113206. Epub 2021 Dec 11. N Engl J Med. 2022. PMID: 34891223 Clinical Trial.
[Gene therapy in beta-thalassemia].
Thuret I. Thuret I. Transfus Clin Biol. 2021 Nov;28(4):405-406. doi: 10.1016/j.tracli.2021.09.001. Epub 2021 Sep 6. Transfus Clin Biol. 2021. PMID: 34500092 French. No abstract available.
Recent results of hematopoietic stem cell transplantation for thalassemia with busulfan-based conditioning regimen in France: improved thalassemia free survival despite frequent mixed chimerism. A retrospective study from the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC).
Rossi M, Szepetowski S, Yakouben K, Paillard C, Sirvent A, Castelle M, Pegon C, Piguet C, Grain A, Angoso M, Robin M, Dhedin N, Pondarré C, Dumesnil de Maricourt C, Berceanu A, Simon P, Marcais A, Poirée M, Gandemer V, Plantaz D, Nguyen S, Michel G, Loundou A, Dalle JH, Thuret I. Rossi M, et al. Among authors: thuret i. Bone Marrow Transplant. 2023 Nov;58(11):1254-1256. doi: 10.1038/s41409-023-02079-0. Epub 2023 Aug 4. Bone Marrow Transplant. 2023. PMID: 37542188 No abstract available.
[Neonatal screening of sickle cell anemia in metropolitan France].
Bardakjian J, Benkerrou M, Bernaudin F, Briard ML, Ducrocq R, Lambilliotte A, Léna-Russo D, de Montalembert M, Thuret I, Bégué P, Elion J, Galactéros F; Travail du Groupe sur le dépistage néonatal de la drépanocytose. Bardakjian J, et al. Among authors: thuret i. Arch Pediatr. 2000 Dec;7(12):1261-3. doi: 10.1016/s0929-693x(00)00140-8. Arch Pediatr. 2000. PMID: 11147058 French. No abstract available.
Pregnancy outcome in women with transfused beta-thalassemia in France.
Virot E, Thuret I, Jardel S, Herbrecht R, Lachenal F, Lionnet F, Lucchini MJ, Machin J, Nimubona S, Ribeil JA, Galacteros F, Cannas G, Hot A. Virot E, et al. Among authors: thuret i. Ann Hematol. 2022 Feb;101(2):289-296. doi: 10.1007/s00277-021-04697-4. Epub 2021 Oct 20. Ann Hematol. 2022. PMID: 34668980
120 results